SRC and cancer: Interestingly, the ESR1/ESR2 ratio was characterized by a strong, negative correlation with ESR2/PELP1 ratio in OCP, and moderately strong with ESR2/SRC ratio in both benign changes of ovary and cancer affected tissue.